Structure Therapeutics Inc. Sponsored ADR GPCR

35.93 (0.09) (0.25%) as of 25 Sep
Market cap
$2.6B
P/E
0.0×

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Net Income
(214.83) (170.34) (141.20) (210.68)

+8 more TTM periods

Depreciation & Amortization
5.14 3.93 1.68 0.81
Non Cash Items (Other)
16.65 11.32 5.37 10.37
Accounts Payable Change
2.14 (0.89) 4.77 9.35
Change in payables and accrued liability
24.28 22.37 21.51 9.52
Change in other assets and liabilities
(53.67) (21.14) (14.32) (13.61)
Operating Cash Flow
(220.29) (154.74) (222.20) (194.25)
Capital expenditures
(4.21) (4.48) (3.61) (2.13)
Short Term Investments Change (Net)
(421.67) (446.95) 83.16 63.86
Other investing activities
— — — 2.09
Investing cash flow
(415.63) (441.18) 89.80 66.89
Equity Repurchase (Common, Net)
766.63 765.06 765.15 59.53
Other financial activities
(5.09) (5.09) (2.64) (1.39)
Financing cash flow
761.53 759.97 762.52 58.14
Change in Cash
125.61 164.05 630.11 (69.22)
Beginning Cash
799.62 799.62 169.51 169.51
Ending Cash
925.24 963.67 799.62 100.29
Stock Based Compensation
39.84 34.71 28.99 26.75
Dividends Paid (Common)
0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
(27.25) 0.35 (88.04) 5.26
Investments Change (Net)
(411.42) (436.70) 93.41 63.86
Issuance/Purchase of Shares
766.63 765.06 765.15 59.53

Fold the line items

In millions of $ except per-share values · columns are period end dates